These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

804 related items for PubMed ID: 10336836

  • 1. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
    Lijnen P, Petrov V.
    J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
    [Abstract] [Full Text] [Related]

  • 2. Antagonism of the renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
    Lijnen P, Petrov V.
    Methods Find Exp Clin Pharmacol; 1999 Jun; 21(5):363-74. PubMed ID: 10420393
    [Abstract] [Full Text] [Related]

  • 3. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.
    Dostal DE, Hunt RA, Kule CE, Bhat GJ, Karoor V, McWhinney CD, Baker KM.
    J Mol Cell Cardiol; 1997 Nov; 29(11):2893-902. PubMed ID: 9405164
    [Abstract] [Full Text] [Related]

  • 4. Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.
    Sadoshima J, Izumo S.
    Circ Res; 1993 Sep; 73(3):413-23. PubMed ID: 8348686
    [Abstract] [Full Text] [Related]

  • 5. Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist.
    Haddad GE, Blackwell K, Bikhazi A.
    Can J Physiol Pharmacol; 2003 Feb; 81(2):142-9. PubMed ID: 12710528
    [Abstract] [Full Text] [Related]

  • 6. Cellular physiology of rat cardiac myocytes in cardiac fibrosis: in vitro simulation using the cardiac myocyte/cardiac non-myocyte co-culture system.
    Ikeda K, Tojo K, Udagawa T, Otsubo C, Ishikawa M, Tokudome G, Hosoya T, Tajima N, Nakao K, Kawamura M.
    Hypertens Res; 2008 Apr; 31(4):693-706. PubMed ID: 18633182
    [Abstract] [Full Text] [Related]

  • 7. TGF-beta1 and angiotensin networking in cardiac remodeling.
    Rosenkranz S.
    Cardiovasc Res; 2004 Aug 15; 63(3):423-32. PubMed ID: 15276467
    [Abstract] [Full Text] [Related]

  • 8. Ca(2+)-growth coupling in angiotensin II-induced hypertrophy in cultured rat cardiac cells.
    Kinugawa K, Takahashi T, Kohmoto O, Yao A, Ikenouchi H, Serizawa T.
    Cardiovasc Res; 1995 Sep 15; 30(3):419-31. PubMed ID: 7585834
    [Abstract] [Full Text] [Related]

  • 9. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction.
    Yamazaki T, Shiojima I, Komuro I, Nagai R, Yazaki Y.
    J Hypertens Suppl; 1994 Dec 15; 12(10):S153-7. PubMed ID: 7769485
    [Abstract] [Full Text] [Related]

  • 10. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy.
    Baker KM, Chernin MI, Schreiber T, Sanghi S, Haiderzaidi S, Booz GW, Dostal DE, Kumar R.
    Regul Pept; 2004 Aug 15; 120(1-3):5-13. PubMed ID: 15177915
    [Abstract] [Full Text] [Related]

  • 11. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
    Zhou DX, Liang QS, He XX, Zhan CY.
    Zhongguo Zhong Yao Za Zhi; 2008 Apr 15; 33(8):936-9. PubMed ID: 18619357
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
    Zhang SQ, Ding B, Guo ZG, Li YX.
    Acta Pharmacol Sin; 2004 Jan 15; 25(1):41-6. PubMed ID: 14704121
    [Abstract] [Full Text] [Related]

  • 13. Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro.
    Hirata Y, Kanno K, Eguchi S, Kano H.
    Blood Press Suppl; 1994 Jan 15; 5():84-8. PubMed ID: 7889209
    [Abstract] [Full Text] [Related]

  • 14. The renin-angiotensin system and experimental heart failure.
    Wollert KC, Drexler H.
    Cardiovasc Res; 1999 Sep 15; 43(4):838-49. PubMed ID: 10615411
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, Loibner H, Wang XH, Penninger JM, Kassiri Z, Oudit GY.
    Circulation; 2010 Aug 17; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy.
    Hoffmann S, Krause T, van Geel PP, Willenbrock R, Pagel I, Pinto YM, Buikema H, van Gilst WH, Lindschau C, Paul M, Inagami T, Ganten D, Urata H.
    J Mol Med (Berl); 2001 Oct 17; 79(10):601-8. PubMed ID: 11692158
    [Abstract] [Full Text] [Related]

  • 18. Effects of losartan and PD123319 on antigensin II-induced proto-oncogene expression and protein synthesis in cultured neonatal rat cardiac myocytes.
    Ling Q, Guo Z, Chen T, Yu Y.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Oct 17; 22(4):283-6. PubMed ID: 9868075
    [Abstract] [Full Text] [Related]

  • 19. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
    Rajapurohitam V, Javadov S, Purdham DM, Kirshenbaum LA, Karmazyn M.
    J Mol Cell Cardiol; 2006 Aug 17; 41(2):265-74. PubMed ID: 16806260
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.